J Rheum Dis 2025; 32(1): 68-68
Published online January 1, 2025
© Korean College of Rheumatology
Correspondence to : Sang-Won Lee, https://orcid.org/0000-0002-8038-3341
Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea. E-mail: sangwonlee@yuhs.ac
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
J Rheum Dis 2023;30(1):45-52
https://doi.org/10.4078/jrd.22.0033
We discovered that a missing word in the
The corrected version should be as follows:
Patients with AAV receiving rituximab and having serious infection (n=33)
Patients with AAV receiving rituximab and having
We sincerely apologize for any confusion that we may have caused.
J Rheum Dis 2025; 32(1): 68-68
Published online January 1, 2025 https://doi.org/10.4078/jrd.22.0033E
Copyright © Korean College of Rheumatology.
Hyunsue Do, M.D.1, Jung Yoon Pyo, M.D.1,2, Jason Jungsik Song, M.D., Ph.D.1,2, Yong-Beom Park, M.D., Ph.D.1,2, Sang-Won Lee, M.D., Ph.D.1,2
1Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, 2Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Korea
Correspondence to:Sang-Won Lee, https://orcid.org/0000-0002-8038-3341
Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea. E-mail: sangwonlee@yuhs.ac
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
J Rheum Dis 2023;30(1):45-52
https://doi.org/10.4078/jrd.22.0033
We discovered that a missing word in the
The corrected version should be as follows:
Patients with AAV receiving rituximab and having serious infection (n=33)
Patients with AAV receiving rituximab and having
We sincerely apologize for any confusion that we may have caused.